Clinical Trials
3
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Efficacy and Safety Study of Aplindore in Patients With Restless Legs Syndrome
- First Posted Date
- 2009-02-03
- Last Posted Date
- 2009-10-14
- Lead Sponsor
- Neurogen Corporation
- Target Recruit Count
- 230
- Registration Number
- NCT00834327
- Locations
- 🇺🇸
HOPE Research Institute, Phoenix, Arizona, United States
🇺🇸Genova Clinical Research, Tuscon, Arizona, United States
🇺🇸Excell Research, Inc., Oceanside, California, United States
Efficacy and Safety Study of Aplindore in Patients With Early Parkinson Disease
- Conditions
- Early Parkinson Disease
- Interventions
- First Posted Date
- 2008-12-17
- Last Posted Date
- 2009-08-28
- Lead Sponsor
- Neurogen Corporation
- Target Recruit Count
- 9
- Registration Number
- NCT00809302
- Locations
- 🇺🇸
University of Alabama At Birmingham (052), Birmingham, Alabama, United States
🇺🇸Mayo Clinic Arizona (060), Scottsdale, Arizona, United States
🇺🇸The Parkinson's Institute (012), Sunnyvale, California, United States
Efficacy and Safety Study of Adipiplon, Placebo and an Active Control in Primary Insomniacs
- First Posted Date
- 2008-05-23
- Last Posted Date
- 2008-07-22
- Lead Sponsor
- Neurogen Corporation
- Target Recruit Count
- 84
- Registration Number
- NCT00683436
- Locations
- 🇺🇸
Broward Research Group, Pembroke Pines, Florida, United States
🇺🇸Miami Research Associates, South Miami, Florida, United States
🇺🇸Neurotrials Research, Inc, Atlanta, Georgia, United States